Jacob Edelstein

Jacob Edelstein is a seasoned professional in the pharmaceutical and digital marketing industries, currently serving as a Neuroscience Sales Specialist at Intra-Cellular Therapies since February 2020, where Jacob launched Caplyta for the treatment of bipolar disorder and schizophrenia and received multiple National Summit Awards. Prior roles include Digital Brand Strategist at 2060 Digital, Pharmacogenomics Sales Specialist at Alpha Genomix Laboratories, and Central Nervous System Specialty Representative at Allergan. Jacob's career began as an Account Executive at Viamedia after an internship at Hackman Capital Partners. Jacob holds a Bachelor of Business degree in Finance from Ohio University.